Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: The pathophysiological role of GLP1 and its response to a somatostatin analogue

European Journal of Endocrinology

Volumn 166, Issue 5, 2012, Pages 951-955

  Myint, K S ^a,d   Greenfield, J R ^a   Farooqi, I S ^a   Henning, E ^a   Holst, J J ^b   Finer, N ^a,c  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; C PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; METFORMIN; OCTREOTIDE; PROINSULIN; SOMATOSTATIN DERIVATIVE;

ADULT; ARTICLE; BODY MASS; CASE REPORT; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESPONSE; METABOLIC DISORDER; NEUROGLYCOPAENIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPONTANEOUS HYPERINSULINAEMIC HYPOGLYCEMIA; STOMACH BYPASS; TEST MEAL; TREATMENT OUTCOME;

ADULT; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; NESIDIOBLASTOSIS; OCTREOTIDE; SOMATOSTATIN; TIME FACTORS;

EID: 84862078678     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-1065     Document Type: Article

References (32)

1. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, de Ramon RA, Israel GDolezal JM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Annals of Surgery 1995 222 339-350. (doi:10.1097/00000658-199509000- 00011)
2. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K & Schoelles K. Bariatric surgery: a systematic review and meta-analysis. Journal of the American Medical Association 2004 292 1724-1737. (doi:10.1001/jama.292. 14.1724)
3. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo- Clavell ML & Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. New England Journal of Medicine 2005 353 249-254. (doi:10.1056/NEJMoa043690)
4. Scavini M, Pontiroli AE & Folli F. Asymptomatic hyperinsulinemic hypoglycemia after gastric banding. New England Journal of Medicine 2005 353 2822-2823. (doi:10.1056/NEJMc052356)
5. Vezzosi D, Bennet A, Fauvel J & Caron P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. European Journal of Endocrinology 2007 157 75-83. (doi:10.1530/EJE-07-0109)
6. Hampton SM, Beyzavi K, Teale D & Marks V. A direct assay for proinsulin in plasma and its applications in hypoglycaemia. Clinical Endocrinology 1988 29 9-16. (doi:10.1111/j.1365-2265.1988.tb00244.x)
7. Meier JJ, Butler AE, Galasso R & Butler PC. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 2006 29 1554-1559. (doi:10.2337/dc06-0392)
8. Korner J, Bessler M, Inabnet W, Taveras C & Holst JJ. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surgery for Obesity and Related Diseases 2007 3 597-601. (doi:10.1016/j.soard.2007.08.004)
9. Patti ME & Goldfine AB. Hypoglycaemia following gastric bypass surgery - diabetes remission in the extreme? Diabetologia 2010 53 2276-2279. (doi:10.1007/s00125-010-1884-8)
10. Toft-Nielsen M, Madsbad S & Holst JJ. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 1998 41 1180-1186. (doi:10.1007/s001250051049)
11. Miholic J, Orskov C, Holst JJ, Kotzerke J & Meyer HJ. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Digestive Diseases and Sciences 1991 36 1361-1370. (doi:10.1007/BF01296800)
12. Gumbs AA, Modlin IM & Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obesity Surgery 2005 15 462-473. (doi:10.1381/0960892053723367)
13. Mason EE. The mechanisms of surgical treatment of type 2 diabetes. Obesity Surgery 2005 15 459-461. (doi:10.1381/0960892053723330)
14. Salehi M, Prigeon RL & D'Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes 2011 60 2308-2314. (doi:10.2337/db11-0203)
15. Olsson R & Carlsson PO. A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 2011 60 2068-2075. (doi:10.2337/db09-0877)
16. Zagury L, Moreira RO, Guedes EP, Coutinho WF & Appolinario JC. Insulinoma misdiagnosed as dumping syndrome after bariatric surgery. Obesity Surgery 2004 14 120-123. (doi:10.1381/096089204772787419)
17. Clancy TE, Moore FD Jr & Zinner MJ. Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. Journal of Gastrointestinal Surgery 2006 10 1116-1119. (doi:10.1016/j.gassur.2006.04.008)
18. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S & Goldfine AB. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005 48 2236-2240. (doi:10.1007/s00125-005-1933-x)
19. Alvarez GC, Faria EN, Beck M, Girardon DT & Machado AC. Laparoscopic spleen-preserving distal pancreatectomy as treatment for nesidioblastosis after gastric bypass surgery. Obesity Surgery 2007 17 550-552. (doi:10.1007/s11695- 007-9096-0)
20. Anlauf M, Wieben D, Perren A, Sipos B, Komminoth P, Raffel A, Kruse ML, Fottner C, Knoefel WT, Mönig H, Heitz PU & Klöppel G. Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. American Journal of Surgical Pathology 2005 29 524-533. (doi:10.1097/01.pas. 0000151617.14598.ae)
21. Unger RH & Eisentraut AM. Entero-insular axis. Archives of Internal Medicine 1969 123 261-266. (doi:10.1001/archinte. 1969.00300130043007)
22. Meier JJ & Nauck MA. Glucagon-like peptide 1 (GLP-1) in biology and pathology. Diabetes/Metabolism Research and Reviews 2005 21 91-117. (doi:10.1002/dmrr.538)
23. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R & Marks V. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996 38 916-919. (doi:10.1136/gut.38.6.916)
24. Drucker DJ. Minireview: the glucagon-like peptides. Endocrinology 2001 142 521-527. (doi:10.1210/en.142.2.521)
25. Toft-Nielsen MB, Madsbad S & Holst JJ. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2001 86 3853-3860. (doi:10.1210/jc.86.8.3853)
26. Greenfield JR, Farooqi IS, Keogh JM, Henning E, Habib AM, Blackwood A, Reimann F, Holst JJ & Gribble FM. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. American Journal of Clinical Nutrition 2009 89 106-113. (doi:10. 3945/ajcn.2008.26362)
27. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK & Holst JJ. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism 2001 86 3717-3723.(doi:10.1210/jc.86.8.3717)
28. Holst JJ. The physiology of glucagon-like peptide 1. Physiological Reviews 2007 87 1409-1439. (doi:10.1152/physrev.00034.2006)
29. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG & Aylwin SJ. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. British Journal of Surgery 2006 93 210-215. (doi:10.1002/bjs.5227)
30. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ & Patti ME. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. Journal of Clinical Endocrinology and Metabolism 2007 92 4678-4685. (doi:10.1210/jc.2007-0918)
31. McLaughlin T, Peck M, Holst J & Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. Journal of Clinical Endocrinology and Metabolism 2010 95 1851-1855. (doi:10.1210/jc.2009-1628)
32. Z'graggen K, Guweidhi A, Steffen R, Potoczna N, Biral R, Walther F, Komminoth P & Horber F. Severe recurrent hypoglycemia after gastric bypass surgery. Obesity Surgery 2008 18 981-988. (doi:10.1007/s11695-008-9480-4)